21 results
P
non-ICU patients
I/C
acid-suppressive medications, placebos (gastric mucosa protectants), H2-receptor antagonists, proton pump inhibitors (PPIs)
O
occurrence of SU bleeding, adverse drug events (ADEs)
P
E2F4, FOXM1, TFDP1, E2F1, SIN3A, JUN, DDX4, FOSL1, NOC2L, HMGA1, CDK1, CCNB1, AURKA, CDC20, CCNA2, SCNN1A, CDCA3, SOX6
I/C
O
survival prognosis, immune infiltrations, diagnostic efficacy
P
fractures involving the posterior malleolus (PM) of the ankle
I/C
cannulated screws versus plate with screw fixation, no statistically significant difference in the development of postoperative ankle osteoarthritis and functional outcomes
O
no significant difference in the development of postoperative ankle osteoarthritis and functional outcomes
P
soggetti esposti professionalmente a glifosato
I/C
esposizione professionale a glifosato, soggetti non esposti a glifosato
O
rischio di linfoma non Hodgkin (NHL) e mieloma multiplo (MM)
P
older adults without cognitive impairment
I/C
anticholinergic medications, cognitive decline or dementia
O
risk of cognitive decline or dementia
P
patients with dry eye
I/C
autologous serum treatment, artificial tear drops
O
adverse effects, quality of life, severity of the pathology, pain, corneal epitheliopathy grade
P
patients with knee osteoarthritis
I/C
offloader knee braces, use of offloader knee braces vs. no use
O
physical function, pain, quality of life, adverse events
P
8050 patients
I/C
Cyclosporine + methotrexate + Anti-T cell globulin (ATG), tacrolimus + methotrexate + ATG, tacrolimus + bortezomib + sirolimus, cyclosporine + marrow mesenchymal stem cells (MMSCs), corticosteroids alone
O
proportion of patients who respond to therapies
P
adults
I/C
heterologous immunization schedules, homologous immunization schedules, different heterologous and homologous regimens
O
neutralizing antibodies against the original strain, serious adverse events (SAEs)
P
cancer patients
I/C
direct-acting oral anticoagulants, low molecular weight heparin
O
major bleeding, thromboembolic disease, quality of life, mortality